Incidência de doença pulmonar intersticial em pacientes com artrite reumatoide tratados com medicamentos biológicos e sintéticos direcionados modificadores da doença
JAMA Netw Open. 2023;6(3):e233640 doi: 10.1001/jamanetworkopen.2023.3640
Retrospective cohort study results suggest that treatment with tofacitinib, and perhaps other JAK inhibitors, may provide a benefit in reducing the risk of developing RA-Interstitial Lung Disease (ILD).